Rare diseases
Investigational molecules
Locations
Back to Romania1 clinical trial in Focsani, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)RomaniaThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on Major Depressive Disorder (MDD) treatments, particularly examining innovative combination therapies for patients with specific symptoms.
These trials evaluate new therapeutic agents as add-ons to existing SSRI/SNRI antidepressants, aiming to improve treatment outcomes for patients with inadequate response to standard care.
Investigating the relationship between sleep disorders and depression through targeted therapeutic interventions, specifically examining seltorexant's effectiveness in treating concurrent depression and insomnia.
Research focuses on both short-term symptom improvement and long-term relapse prevention strategies.
Studies examining novel approaches for patients with inadequate response to conventional antidepressant treatments, including the evaluation of aticaprant and seltorexant.
These trials aim to establish new therapeutic options for patients who don't achieve optimal results with standard treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
